Literature DB >> 19672877

Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase.

David C Marciano1, Nicholas G Brown, Timothy Palzkill.   

Abstract

A large number of beta-lactamases have emerged that are capable of conferring bacterial resistance to beta-lactam antibiotics. Comparison of the structural and functional features of this family has refined understanding of the catalytic properties of these enzymes. An arginine residue present at position 244 in TEM-1 beta-lactamase interacts with the carboxyl group common to penicillin and cephalosporin antibiotics and thereby stabilizes both the substrate and transition state complexes. A comparison of class A beta-lactamase sequences reveals that arginine at position 244 is not conserved, although a positive charge at this structural location is conserved and is provided by an arginine at positions 220 or 276 for those enzymes lacking arginine at position 244. The plasticity of the location of positive charge in the beta-lactamase active site was experimentally investigated by relocating the arginine at position 244 in TEM-1 beta-lactamase to positions 220, 272, and 276 by site-directed mutagenesis. Kinetic analysis of the engineered beta-lactamases revealed that removal of arginine 244 by alanine mutation reduced catalytic efficiency against all substrates tested and restoration of an arginine at positions 272 or 276 partially suppresses the catalytic defect of the Arg244Ala substitution. These results suggest an evolutionary mechanism for the observed divergence of the position of positive charge in the active site of class A beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672877      PMCID: PMC2786972          DOI: 10.1002/pro.220

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  The structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

2.  A family of evolution-entropy hybrid methods for ranking protein residues by importance.

Authors:  I Mihalek; I Res; O Lichtarge
Journal:  J Mol Biol       Date:  2004-03-05       Impact factor: 5.469

3.  Overexpression and biosynthetic deuterium enrichment of TEM-1 beta-lactamase for structural characterization by magnetic resonance methods.

Authors:  A Sosa-Peinado; D Mustafi; M W Makinen
Journal:  Protein Expr Purif       Date:  2000-07       Impact factor: 1.650

4.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

5.  Sequence of PSE-2 beta-lactamase.

Authors:  P Huovinen; S Huovinen; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.

Authors:  B Jaurin; T Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.

Authors:  David C Marciano; Jeanine M Pennington; Xiaohu Wang; Jian Wang; Yu Chen; Veena L Thomas; Brian K Shoichet; Timothy Palzkill
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

8.  The crystal structure of the beta-lactamase of Streptomyces albus G at 0.3 nm resolution.

Authors:  O Dideberg; P Charlier; J P Wéry; P Dehottay; J Dusart; T Erpicum; J M Frère; J M Ghuysen
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

9.  Insights into the acylation mechanism of class A beta-lactamases from molecular dynamics simulations of the TEM-1 enzyme complexed with benzylpenicillin.

Authors:  Natalia Díaz; Tomás L Sordo; Kenneth M Merz; Dimas Suárez
Journal:  J Am Chem Soc       Date:  2003-01-22       Impact factor: 15.419

10.  The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family.

Authors:  B Joris; J M Ghuysen; G Dive; A Renard; O Dideberg; P Charlier; J M Frère; J A Kelly; J C Boyington; P C Moews
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

View more
  20 in total

1.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

2.  Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.

Authors:  Bartlomiej G Fryszczyn; Carolyn J Adamski; Nicholas G Brown; Kacie Rice; Wanzhi Huang; Timothy Palzkill
Journal:  Protein Sci       Date:  2014-07-01       Impact factor: 6.725

3.  Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.

Authors:  Emilia Caselli; Chiara Romagnoli; Rachel A Powers; Magdalena A Taracila; Alexandra A Bouza; Hollister C Swanson; Kali A Smolen; Francesco Fini; Bradley J Wallar; Robert A Bonomo; Fabio Prati
Journal:  ACS Infect Dis       Date:  2017-12-08       Impact factor: 5.084

4.  Fitness Effects of Single Amino Acid Insertions and Deletions in TEM-1 β-Lactamase.

Authors:  Courtney E Gonzalez; Paul Roberts; Marc Ostermeier
Journal:  J Mol Biol       Date:  2019-04-26       Impact factor: 5.469

5.  Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Kerri M Smith; Yan Xu; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

6.  Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.

Authors:  Christopher R Bethel; Magdalena Taracila; Teresa Shyr; Jodi M Thomson; Anne M Distler; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Krisztina Papp-Wallace; Richard Bonnet; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

7.  Deep sequencing of systematic combinatorial libraries reveals β-lactamase sequence constraints at high resolution.

Authors:  Zhifeng Deng; Wanzhi Huang; Erol Bakkalbasi; Nicholas G Brown; Carolyn J Adamski; Kacie Rice; Donna Muzny; Richard A Gibbs; Timothy Palzkill
Journal:  J Mol Biol       Date:  2012-09-25       Impact factor: 5.469

8.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

9.  Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis.

Authors:  Nicholas G Brown; Sreejesh Shanker; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

10.  Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.

Authors:  Sebastian G Kurz; Kerstin A Wolff; Saugata Hazra; Christopher R Bethel; Andrea M Hujer; Kerri M Smith; Yan Xu; Lee W Tremblay; John S Blanchard; Liem Nguyen; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.